Results 1 to 10 of about 6,069 (180)

Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma Models. [PDF]

open access: yesCells
Background: Neuroblastoma (NB) causes about 15% of cancer deaths in childhood. Recently, we suggested cell-surface nucleolin (NCL) as a novel target for preclinical therapy against NB.
Bensa V   +9 more
europepmc   +2 more sources

Anti-CD133-grafted single-walled carbon nanotubes as doxorubicin carrier. [PDF]

open access: yesBiol Proced Online
Background Advances in nanomedicine have spurred interest in antibody-conjugated carbon nanotubes for targeted cancer therapy. CD133, a marker enriched in chemoresistant cancer stem cells, presents a strategic target for precision drug delivery.
Momeni E   +4 more
europepmc   +2 more sources

Daixie recipe ameliorates diet-induced MASH in mice <i>via</i> activating PI3K/AKT and Keap1/Nrf2 signaling. [PDF]

open access: yesFront Endocrinol (Lausanne)
BackgroundMetabolic dysfunction-associated steatohepatitis (MASH) is a highly prevalent liver disease that can progress to cirrhosis and hepatocellular carcinoma. Despite its growing clinical burden, effective therapies remain limited. Daixie recipe (DXR)
He X   +18 more
europepmc   +2 more sources

Doxorubicin-induced renal inflammation in rats: Protective role of Plantago major [PDF]

open access: yesAvicenna Journal of Phytomedicine, 2018
Objective: The aim of the present study was to evaluate the possible protective effect of Plantago major (P. major) extract against doxorubicin (DXR)-induced renal inflammation in rats.
Nazanin Entezari Heravi   +11 more
doaj   +1 more source

Cortical hand bone porosity and its association with distal radius fracture in middle aged and elderly women. [PDF]

open access: yesPLoS ONE, 2013
OBJECTIVE: Reduced bone mineral density (BMD), assessed by Dual Energy X-ray absorptiometry (DXA), is a well-known risk factor for fragility fracture. A large proportion of patients with fracture have only slightly reduced BMD.
Alvilde Dhainaut   +3 more
doaj   +1 more source

Therapeutic effect of valsartan against doxorubicin-induced renal toxicity in rats [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2019
Objective(s): Doxorubicin (DXR)-induces glomerular atrophy and fibrosis in rat kidneys. The objective of the current study was to investigate the protective effects of valsartan on DXR-induced glomerular toxicity and its mechanisms of actions in rats ...
Hai-Xia Liu, Jin Li, Qi-Xiong Li
doaj   +1 more source

Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice. [PDF]

open access: yesPLoS ONE, 2015
Advances in cancer treatment utilizing multiple chemotherapies have dramatically increased cancer survivorship. Female cancer survivors treated with doxorubicin (DXR) chemotherapy often suffer from an acute impairment of ovarian function, which can ...
Jenna Kropp   +5 more
doaj   +1 more source

Doxorubicin-induced vascular toxicity--targeting potential pathways may reduce procoagulant activity. [PDF]

open access: yesPLoS ONE, 2013
Previous study in mice using real-time intravital imaging revealed an acute deleterious effect of doxorubicin (DXR) on the gonadal vasculature, as a prototype of an end-organ, manifested by a reduction in blood flow and disintegration of the vessel wall.
Irit Ben Aharon   +8 more
doaj   +1 more source

Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR

open access: yesFrontiers in Pharmacology, 2022
Background: Although doxorubicin (DXR) is one of the most used anticancer drugs, it can cause life-threatening renal damage. There has been no effective treatment for DXR-induced renal damage until now.Aim: This work aims at examining the potential ...
Ahlam M. Alhusaini   +7 more
doaj   +1 more source

Circ_0001721 enhances doxorubicin resistance and promotes tumorigenesis in osteosarcoma through miR-758/TCF4 axis

open access: yesCancer Cell International, 2021
Background Osteosarcoma (OS) is a common type of bone malignancy that often occurs in children and adolescents. Chemoresistance is a huge barrier to cancer therapy.
Huapeng Guan   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy